SELLAS Life Sciences Group, Inc. (SLS)

4.335 +0.56 (+14.99%) USD  |  NASDAQ  |  Jan 02, 16:00
4.40 +0.06 (+1.50%) After-Hours: 20:00
More

SELLAS Life Sciences Group Quarterly Actual Revenue

Quarterly Actual Revenue Chart

View Quarterly Actual Revenue for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Actual Revenue Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Actual Revenue Range, Past 5 Years

View Quarterly Actual Revenue Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Actual Revenue Benchmarks

View Quarterly Actual Revenue Benchmarks
Start Trial
GT Biopharma, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade